Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)

2013 ◽  
Author(s):  
SM Tolaney ◽  
WT Barry ◽  
CT Dang ◽  
DA Yardley ◽  
B Moy ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Her2 Positive ◽  
Node Negative ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 633-633
Author(s):  
Neil M. Iyengar ◽  
Monica Nancy Fornier ◽  
Steven Sugarman ◽  
Maria Theodoulou ◽  
Tiffany A. Troso-Sandoval ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Feasibility Study ◽  
Phase Ii ◽  
Her2 Positive ◽  
Node Negative ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

2009 ◽  
Vol 15 (4) ◽  
pp. 1452-1459 ◽  
Author(s):  
Nancy U. Lin ◽  
Véronique Diéras ◽  
Devchand Paul ◽  
Dominique Lossignol ◽  
Christos Christodoulou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastases ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Multicenter Phase ◽  
Positive Breast Cancer

scholarly journals LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

2018 ◽  
Vol 171 (3) ◽  
pp. 637-648 ◽  
Author(s):  
Amanda E. D. Van Swearingen ◽  
Marni B. Siegel ◽  
Allison M. Deal ◽  
Maria J. Sambade ◽  
Alan Hoyle ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastases ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Breast Cancer Brain Metastases ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document